Cocus oil pulvis (MCT Coconut Oil — Powder)

Cocus oil pulvis (Coconut Oil Powder)

Organic MCT Coconut Oil Powder 70% (MCT — Medium Chain Triglycerides) attracts considerable attention due to its beneficial properties.

MCT is a type of saturated fats contained in products such as coconut oil, and taking them in powder form is a convenient and versatile way to include these beneficial fats in one's diet.

MCT powder is well known for its potential in providing fast and sustained energy. Unlike long-chain triglycerides, MCTs are rapidly absorbed and metabolized by the body, making them an effective source of fuel, especially for the brain and muscles. In addition, MCTs help control weight by promoting satiety and increase the body's ability to burn fat for energy. They also possess antimicrobial properties that help maintain gut health.

Product Name: Кокосовое масло (порошок), Cocus oil pulvis, Kokosöl Pulver, Aceite de coco en polvo, Huile de coco en poudre, مسحوق زيت جوز الهند, ผงน้ำมันมะพร้าว, Kukun yog‘i kukuni, Кокос майы порошогу, Hindqozu yağı tozu, Хокаи равғани норгил, Kokosų aliejaus milteliai, Kokosriekstu eļļas pulveris, Кокосова олія порошок, אבקת שמן קוקוס.

Synonyms: Кокосовый порошок масла, порошкообразное кокосовое масло, coconut oil powder, powdered coconut oil, spray-dried coconut oil, Kokosölpulver, aceite de coco en polvo, huile de coco en poudre, مسحوق زيت جوز الهند المجفف, ผงน้ำมันมะพร้าวอบแห้ง.

Parts Used: fruit pulp, endosperm, oil from fruit pulp.

Main Indications for Use of Cocus oil pulvis: alimentary hyperlipidemia, functional steatorrhea, fat malabsorption syndrome, atopic dermatitis, skin xerosis, seborrheic dermatitis, non-allergic contact dermatitis, skin cracks, chronic cheilitis, dry eye syndrome.

Indications for Use of Cocus oil pulvis in mixtures and complexes: metabolic syndrome, alimentary obesity, type 2 diabetes mellitus, chronic gastritis with reduced secretory function, irritable bowel syndrome, mucosal candidiasis, acne vulgaris, plaque psoriasis, diffuse alopecia.

Main Pharmacological Properties of Cocus oil pulvis: antibacterial, antifungal, antiviral, emollient, reparative, antioxidant, anti-inflammatory, immunomodulatory, hypolipidemic, keratoprotective.

Pharmacological Forms:

• Powder
• Dry Extract
• Tincture
• Oil Infusion
• Vaginal Suppositories
• Rectal Suppositories
• Nasal Drops
• Ear Drops
• Ointment
• Cream
• Cosmetic Serum
• Lip Balm

Dosage of Pharmacological Forms — Cocus oil pulvis

Powder — Cocus oil pulvis

Indications (Powder): alimentary hyperlipidemia, fat malabsorption syndrome, functional steatorrhea, atopic dermatitis, skin xerosis, seborrheic dermatitis.

Standard Dosage (Powder): for oral administration — 5–10 grams per day, divided into 2 doses with meals, course duration — 14–30 days. For topical use, apply to affected skin areas 1–2 times a day in a thin layer.

Enhanced Dosage (Powder): 15 grams per day orally, divided into 3 doses, for severe alimentary hyperlipidemia and fat malabsorption syndrome, course duration — up to 30 days. Topically — 3 times a day for severe skin xerosis and atopic dermatitis.

Maximum Dosage (Powder): 20 grams per day orally under specialist supervision for functional steatorrhea, course duration — up to 14 days. Topically — up to 4 times a day for chronic seborrheic dermatitis.

Preventive Dosage (Powder): 3–5 grams per day with meals for chronic alimentary hyperlipidemia and a tendency to dry skin, frequency — in courses of 14 days with an interval of 30 days.

Pediatric Dosage (Powder): allowed from 3 years of age with body weight not less than 15 kilograms, 1–3 grams per day with meals, course duration — up to 14 days. Topically — once a day in a thin layer.

Contraindications (Powder): individual hypersensitivity to coconut processing products, acute pancreatitis, severe hypertriglyceridemia. Data on contraindications during pregnancy, lactation, and childhood under 3 years of age have not been scientifically registered.

Side Effects (Powder): with overdose, osmotic diarrhea, flatulence, nausea are possible.

Adjustment for Patient Body Weight: for body weight below 60 kilograms, a reduction of dosage by 20 percent is recommended; for body weight above 60 kilograms, an increase of dosage by 10–15 percent is allowed.

Preparation Method (Powder): for the preparation of 100 grams of product: 60 grams of natural cold-pressed coconut oil, 40 grams of organic tapioca maltodextrin. Heat the oil in a water bath at a temperature not exceeding +40 °C until liquid, gradually introduce maltodextrin with constant stirring until a homogeneous mass is formed. Dry the mixture by spray drying or in a dehydrator at a temperature not exceeding +45 °C until a dry powder is obtained. Quality control — absence of lumps and uniform texture.

Storage Conditions and Shelf Life (Powder): store at a temperature from +5 °C to +25 °C in a dry place protected from direct sunlight and electromagnetic radiation. Shelf life — 12 months. After opening the package, use within 60 days.

Dry Extract — Cocus oil pulvis

Indications (Dry Extract): atopic dermatitis, non-allergic contact dermatitis, skin xerosis, seborrheic dermatitis, dry eye syndrome, chronic cheilitis.

Standard Dosage (Dry Extract): in the form of dry extract — 500–1000 milligrams 2 times a day for oral administration, course duration — 14–21 days. Topically — preparation of a solution for applications at a concentration of 5 percent, apply 2 times a day.

Enhanced Dosage (Dry Extract): 1500 milligrams 2 times a day for severe atopic dermatitis, course duration — up to 30 days. Topically — 10 percent solution 3 times a day.

Maximum Dosage (Dry Extract): 3000 milligrams per day orally under specialist supervision for chronic seborrheic dermatitis, course duration — up to 14 days.

Preventive Dosage (Dry Extract): 500 milligrams once a day for a tendency to dry skin and recurrent dermatitis, in courses of 14 days every 2 months.

Pediatric Dosage (Dry Extract): from 6 years of age with body weight not less than 20 kilograms, 250–500 milligrams 1–2 times a day, course duration — up to 14 days.

Contraindications (Dry Extract): individual hypersensitivity to extract components, acute pancreatitis. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Dry Extract): with overdose, dyspeptic disorders are possible.

Adjustment for Patient Body Weight: for body weight below 60 kilograms — reduction of dosage by 20 percent; above 60 kilograms — an increase of 10 percent is allowed.

Preparation Method (Dry Extract): for the preparation of 100 grams of product: 80 grams of dried coconut pulp, 300 milliliters of 70 percent ethanol for extraction. Grind the raw material, pour ethanol, infuse for 48 hours at a temperature not exceeding +25 °C in a dark place. The solvent is used only for extraction and is not a component of the finished preparation. After infusion, filter and completely remove ethanol by evaporation in a water bath at a temperature not exceeding +50 °C until the solvent odor completely disappears. Permissible residual ethanol content — no more than 5000 ppm in accordance with pharmacopoeial standards for topical products. The use of the intermediate product containing liquid solvent as a medicinal product is unacceptable. Dry the obtained concentrate at a temperature not exceeding +45 °C to a powder state.

Storage Conditions and Shelf Life (Dry Extract): store at a temperature from +5 °C to +25 °C, in an airtight package protected from light and moisture. Shelf life — 18 months. After opening, use within 90 days.

Alcohol-Based Tincture — Cocus oil pulvis

Indications (Tincture): seborrheic dermatitis, atopic dermatitis, non-allergic contact dermatitis, skin xerosis, chronic cheilitis, mucosal candidiasis.

Standard Dosage (Tincture): in the form of Tincture — apply topically as a 5 percent solution 2 times a day to affected skin or mucous membrane areas, course duration — 10–14 days.

Enhanced Dosage (Tincture): at a concentration of 10 percent — apply 3 times a day for severe seborrheic dermatitis and mucosal candidiasis, course duration — up to 21 days.

Maximum Dosage (Tincture): at a concentration of 15 percent topically 3–4 times a day under specialist supervision for chronic dermatitis, course duration — up to 14 days.

Preventive Dosage (Tincture): at a concentration of 3–5 percent once a day for a tendency to dry skin and recurrent dermatitis, in courses of 7–10 days every 2 months.

Pediatric Dosage (Tincture): from 6 years of age with body weight not less than 20 kilograms, concentration 3–5 percent 1–2 times a day, course duration — up to 7 days.

Contraindications (Tincture): individual hypersensitivity, skin damage with compromised integrity, childhood under 6 years of age. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Tincture): with overdose, local irritation, erythema, burning sensation are possible.

Adjustment for Patient Body Weight: for topical use, adjustment for body weight is not required.

Preparation Method (Tincture): for the preparation of 100 grams of product: 20 grams of coconut oil powder, 80 milliliters of 70 percent ethanol. Place the raw material in a glass container, pour ethanol, keep for 7 days at a temperature not exceeding +25 °C in a dark place with daily stirring. The solvent is used only for extraction and is not a component of the finished preparation when obtaining a dry concentrate. To obtain a concentrated form, filter and, if necessary, partially evaporate at a temperature not exceeding +50 °C until the volume is reduced and the desired concentration is achieved. Control indicator for removal of excess solvent — reduction in the intensity of alcohol odor. Permissible residual ethanol content in topical products — within pharmacopoeial standards. The use of the intermediate product containing liquid solvent in concentrations above the norms as a medicinal product is unacceptable.

Storage Conditions and Shelf Life (Tincture): store at a temperature from +5 °C to +20 °C in a tightly closed glass container protected from light and sources of electromagnetic radiation. Shelf life — 12 months. After opening, use within 60 days.

Oil Infusion — Cocus oil pulvis

Indications (Oil Infusion): atopic dermatitis, skin xerosis, skin cracks, seborrheic dermatitis, chronic cheilitis, dry eye syndrome.

Standard Dosage (Oil Infusion): in the form of oil infusion — apply topically 2 times a day in a thin layer to affected skin areas, course duration — 14–21 days. When applied to mucous membranes, use at a temperature of +36...+38 °C.

Enhanced Dosage (Oil Infusion): apply 3 times a day for severe skin xerosis and cracks, course duration — up to 30 days.

Maximum Dosage (Oil Infusion): up to 4 times a day for chronic atopic dermatitis under specialist supervision, course duration — up to 21 days.

Preventive Dosage (Oil Infusion): once a day for a tendency to dry skin, in courses of 14 days every 2–3 months.

Pediatric Dosage (Oil Infusion): from 1 year of age, apply 1–2 times a day in a thin layer, course duration — up to 10 days.

Contraindications (Oil Infusion): individual hypersensitivity. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Oil Infusion): with overdose, local allergic reactions are possible.

Adjustment for Patient Body Weight: for topical use, adjustment for body weight is not required.

Preparation Method (Oil Infusion): for the preparation of 100 grams of product: 30 grams of coconut oil powder, 70 grams of natural cold-pressed coconut oil. Place the mixture in a glass container and keep in a water bath at a temperature of up to +50 °C for 2 hours with constant stirring. After infusion, filter through sterile gauze, cool to room temperature. The finished infusion should have a homogeneous oily consistency without signs of separation.

Storage Conditions and Shelf Life (Oil Infusion): store at a temperature from +5 °C to +15 °C in a light-protected place. Shelf life — 6 months. After opening, use within 30 days.

Vaginal Suppositories — Cocus oil pulvis

Indications (Vaginal Suppositories): vulvovaginal candidiasis, atrophic vaginitis, nonspecific vaginitis, vaginal mucosal xerosis.

Standard Dosage (Vaginal Suppositories): "Coconut Oil (Powder)" (Cocus oil pulvis) in the form of suppositories — 1 suppository weighing 2 grams once a day at night, course duration — 7–10 days.

Enhanced Dosage (Vaginal Suppositories): 1 suppository 2 times a day for severe vulvovaginal candidiasis, course duration — up to 14 days.

Maximum Dosage (Vaginal Suppositories): 2 suppositories per day under specialist supervision for chronic recurrent vaginitis, course duration — up to 14 days.

Preventive Dosage (Vaginal Suppositories): 1 suppository every other day for 7 days for a tendency to recurrent vulvovaginal candidiasis.

Pediatric Dosage (Vaginal Suppositories): use under 18 years of age is not recommended; data on safety in childhood have not been scientifically registered.

Contraindications (Vaginal Suppositories): individual hypersensitivity, acute inflammatory diseases of the pelvic organs. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Vaginal Suppositories): with overdose, local burning, itching, mucosal hyperemia are possible.

Adjustment for Patient Body Weight: adjustment for body weight is not required.

Preparation Method (Vaginal Suppositories): "Vaginal Suppositories" for the preparation of 100 grams of product: 60 grams of natural cold-pressed coconut oil, 20 grams of coconut oil powder, 20 grams of cocoa butter. Melt the oils in a water bath at a temperature not exceeding +40 °C, add the powder with constant stirring until a homogeneous mass is formed. Pour into suppository molds weighing 2 grams, cool at a temperature of +5 °C until completely solidified.

Storage Conditions and Shelf Life (Vaginal Suppositories): "Vaginal Suppositories" store at a temperature from +5 °C to +10 °C in a light-protected place. Shelf life — 6 months. After opening the package, use within 30 days.

Rectal Suppositories — Cocus oil pulvis

Indications (Rectal Suppositories): chronic proctitis, chronic anal fissure, internal hemorrhoids, rectal mucosal dryness syndrome.

Standard Dosage (Rectal Suppositories): 1 suppository weighing 2 grams once a day after hygienic procedures, course duration — 7–10 days.

Enhanced Dosage (Rectal Suppositories): 1 suppository 2 times a day for severe chronic proctitis, course duration — up to 14 days.

Maximum Dosage (Rectal Suppositories): 2 suppositories per day under specialist supervision for exacerbation of internal hemorrhoids, course duration — up to 14 days.

Preventive Dosage (Rectal Suppositories): 1 suppository every other day for 7 days for a tendency to chronic anal fissure.

Pediatric Dosage (Rectal Suppositories): from 12 years of age with body weight not less than 40 kilograms, 1 suppository once a day, course duration — up to 7 days.

Contraindications (Rectal Suppositories): individual hypersensitivity, acute paraproctitis. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Rectal Suppositories): with overdose, diarrhea, discomfort in the rectum are possible.

Adjustment for Patient Body Weight: for body weight below 60 kilograms, the use of the standard dosage without increase is recommended; for body weight above 90 kilograms, an increase in frequency to 2 times a day is allowed.

Preparation Method (Rectal Suppositories): "Rectal Suppositories" for the preparation of 100 grams of product: 65 grams of cold-pressed coconut oil, 20 grams of cocoa butter, 15 grams of coconut oil powder. Melt the oils in a water bath at a temperature not exceeding +40 °C, introduce the powder with constant stirring, pour into molds weighing 2 grams, cool until completely solidified at a temperature of +5 °C.

Storage Conditions and Shelf Life (Rectal Suppositories): "Rectal Suppositories" store at a temperature from +5 °C to +10 °C, protect from light and heating. Shelf life — 6 months. After opening, use within 30 days.

Nasal Drops — Cocus oil pulvis

Indications (Nasal Drops): atrophic rhinitis, chronic catarrhal rhinitis, nasal mucosal xerosis, chronic rhinopharyngitis.

Standard Dosage (Nasal Drops): "Coconut Oil (Powder)" (Cocus oil pulvis) in the form of an oil solution at a concentration of 2 percent — 1–2 drops in each nasal passage 2 times a day at a temperature of +36...+38 °C, course duration — 7–10 days.

Enhanced Dosage (Nasal Drops): "Coconut Oil (Powder)" (Cocus oil pulvis) at a concentration of 3–5 percent — 2 drops 3 times a day for severe atrophic rhinitis, course duration — up to 14 days.

Maximum Dosage (Nasal Drops): "Coconut Oil (Powder)" (Cocus oil pulvis) at a concentration of 5 percent — 3 drops 3 times a day under specialist supervision for chronic rhinopharyngitis, course duration — up to 14 days.

Preventive Dosage (Nasal Drops): "Coconut Oil (Powder)" (Cocus oil pulvis) at a concentration of 2 percent — 1 drop once a day for a tendency to dryness of the nasal mucosa, in courses of 7 days every 2 months.

Pediatric Dosage (Nasal Drops): from 3 years of age with body weight not less than 15 kilograms, concentration 1–2 percent, 1 drop 1–2 times a day, course duration — up to 7 days.

Contraindications (Nasal Drops): individual hypersensitivity, acute purulent sinusitis. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Nasal Drops): with overdose, a feeling of nasal congestion, burning of the mucosa are possible.

Adjustment for Patient Body Weight: for topical use, adjustment for body weight is not required.

Preparation Method (Nasal Drops): "Nasal Drops" for the preparation of 100 grams of product: 95 grams of sterile cold-pressed coconut oil, 5 grams of coconut oil powder. Heat the mixture in a water bath at a temperature of up to +40 °C, mix thoroughly until homogeneous, filter through a sterile filter. Before use, warm to a temperature of +36...+38 °C.

Storage Conditions and Shelf Life (Nasal Drops): "Nasal Drops" store at a temperature from +5 °C to +15 °C in a sterile vial protected from light. Shelf life — 3 months. After opening, use within 14 days.

Ear Drops — Cocus oil pulvis

Indications (Ear Drops): non-infectious external otitis, dermatitis of the auditory canal, xerosis of the auditory canal skin.

Standard Dosage (Ear Drops): "Coconut Oil (Powder)" (Cocus oil pulvis) at a concentration of 2–3 percent — 2 drops in the external auditory canal 2 times a day at a temperature of +36...+38 °C, course duration — 5–7 days.

Enhanced Dosage (Ear Drops): "Coconut Oil (Powder)" (Cocus oil pulvis) at a concentration of 5 percent — 3 drops 2–3 times a day for severe dermatitis of the auditory canal, course duration — up to 10 days.

Maximum Dosage (Ear Drops): "Coconut Oil (Powder)" (Cocus oil pulvis) at a concentration of 5 percent — 3 drops 3 times a day under specialist supervision, course duration — up to 10 days.

Preventive Dosage (Ear Drops): "Coconut Oil (Powder)" (Cocus oil pulvis) at a concentration of 2 percent — 1–2 drops once a day for a tendency to dryness of the auditory canal skin, in courses of 5 days every 2–3 months.

Pediatric Dosage (Ear Drops): from 5 years of age with body weight not less than 18 kilograms, concentration 1–2 percent, 1–2 drops 1–2 times a day, course duration — up to 5 days.

Contraindications (Ear Drops): perforation of the tympanic membrane, purulent otitis media, individual hypersensitivity. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Ear Drops): with overdose, a feeling of ear fullness, local irritation are possible.

Adjustment for Patient Body Weight: adjustment for body weight is not required.

Preparation Method (Ear Drops): "Ear Drops" for the preparation of 100 grams of product: 97 grams of sterile cold-pressed coconut oil, 3 grams of coconut oil powder. Heat the mixture in a water bath at a temperature of up to +40 °C, mix until homogeneous, filter through a sterile filter. Before use, warm to a temperature of +36...+38 °C.

Storage Conditions and Shelf Life (Ear Drops): "Ear Drops" store at a temperature from +5 °C to +15 °C, protect from light. Shelf life — 3 months. After opening, use within 14 days.

Ointment — Cocus oil pulvis

Indications (Ointment): atopic dermatitis, non-allergic contact dermatitis, seborrheic dermatitis, plaque psoriasis, skin cracks, chronic eczema.

Standard Dosage (Ointment): apply a thin layer to affected skin areas 2 times a day, course duration — 14–21 days.

Enhanced Dosage (Ointment): apply 3 times a day for severe inflammatory process and hyperkeratosis, course duration — up to 30 days.

Maximum Dosage (Ointment): up to 4 times a day under specialist supervision for chronic eczema and plaque psoriasis, course duration — up to 21 days.

Preventive Dosage (Ointment): once a day for a tendency to recurrent dermatitis, in courses of 14 days every 2–3 months.

Pediatric Dosage (Ointment): from 1 year of age, apply 1–2 times a day in a thin layer, course duration — up to 10 days.

Contraindications (Ointment): individual hypersensitivity, infected wounds without antiseptic treatment. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Ointment): with overdose, local allergic reactions, erythema, itching are possible.

Adjustment for Patient Body Weight: adjustment for body weight is not required.

Preparation Method (Ointment): "Ointment" for the preparation of 100 grams of product: 50 grams of cold-pressed coconut oil, 20 grams of shea butter, 20 grams of beeswax, 10 grams of coconut oil powder. Melt the oils and wax in a water bath at a temperature not exceeding +40 °C, add the powder with constant stirring until a homogeneous mass is obtained. Pour into sterile containers and cool until completely solidified.

Storage Conditions and Shelf Life (Ointment): "Ointment" store at a temperature from +5 °C to +20 °C, protect from light and heating. Shelf life — 12 months. After opening, use within 60 days.

Cream — Cocus oil pulvis

Indications (Cream): skin xerosis, atopic dermatitis, seborrheic dermatitis, acne vulgaris, post-inflammatory hyperpigmentation.

Standard Dosage (Cream): apply to the skin 2 times a day, course duration — 14–30 days.

Enhanced Dosage (Cream): apply 3 times a day for severe dryness and skin inflammation, course duration — up to 30 days.

Maximum Dosage (Cream): up to 4 times a day under specialist supervision for chronic dermatitis, course duration — up to 21 days.

Preventive Dosage (Cream): once a day for a tendency to dry skin, in courses of 30 days every 3 months.

Pediatric Dosage (Cream): from 1 year of age, apply 1–2 times a day in a thin layer, course duration — up to 14 days.

Contraindications (Cream): individual hypersensitivity, severe pustular skin lesions. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Cream): with overdose, comedogenicity, local allergic reactions are possible.

Adjustment for Patient Body Weight: adjustment for body weight is not required.

Preparation Method (Cream): "Cream" for the preparation of 100 grams of product: 40 grams of cold-pressed coconut oil, 20 grams of shea butter, 5 grams of beeswax, 30 milliliters of purified water, 5 grams of coconut oil powder. Heat the oil phase in a water bath at a temperature not exceeding +40 °C, warm the water phase to the same temperature. Combine the phases with constant stirring until an emulsion is obtained, add the powder and stir until homogeneous. Cool at room temperature.

Storage Conditions and Shelf Life (Cream): "Cream" store at a temperature from +5 °C to +20 °C in an airtight package. Shelf life — 6 months. After opening, use within 30 days.

Cosmetic Serum — Cocus oil pulvis

Indications (Cosmetic Serum): skin xerosis, atopic dermatitis in remission, post-inflammatory hyperpigmentation, skin photoaging, fine wrinkles.

Standard Dosage (Cosmetic Serum): apply 1–2 times a day to cleansed skin of the face and neck, course duration — 30 days.

Enhanced Dosage (Cosmetic Serum): apply 2 times a day in combination with a base cream for severe dryness and decreased skin turgor, course duration — up to 45 days.

Maximum Dosage (Cosmetic Serum): up to 3 times a day under specialist supervision for severe photoaging, course duration — up to 30 days.

Preventive Dosage (Cosmetic Serum): once a day in the evening for a tendency to dry skin, in courses of 30 days every 3–4 months.

Pediatric Dosage (Cosmetic Serum): from 12 years of age, apply once a day, course duration — up to 14 days.

Contraindications (Cosmetic Serum): individual hypersensitivity, severe inflammatory skin elements. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Cosmetic Serum): with overdose, comedogenicity, local irritation are possible.

Adjustment for Patient Body Weight: adjustment for body weight is not required.

Preparation Method (Cosmetic Serum): "Cosmetic Serum" for the preparation of 100 grams of product: 50 grams of rose hydrolate, 30 grams of cold-pressed coconut oil, 10 grams of plant-derived glycerin, 10 grams of coconut oil powder. Heat the oil phase to a temperature not exceeding +40 °C, warm the water phase to the same temperature, combine with intensive stirring until a light emulsion is formed, add the powder and stir until a homogeneous consistency.

Storage Conditions and Shelf Life (Cosmetic Serum): "Cosmetic Serum" store at a temperature from +5 °C to +15 °C, protect from light. Shelf life — 3 months. After opening, use within 30 days.

Lip Balm — Cocus oil pulvis

Indications (Lip Balm): chronic cheilitis, lip cracks, lip xerosis, irritation of the lip skin.

Standard Dosage (Lip Balm): apply to the lips 2–3 times a day, course duration — 10–14 days.

Enhanced Dosage (Lip Balm): apply 4 times a day for severe cracks and peeling, course duration — up to 21 days.

Maximum Dosage (Lip Balm): up to 5 times a day under specialist supervision for chronic recurrent cheilitis, course duration — up to 21 days.

Preventive Dosage (Lip Balm): 1–2 times a day during the cold season for a tendency to dry lips, in courses of 30 days.

Pediatric Dosage (Lip Balm): from 3 years of age, apply 1–2 times a day, course duration — up to 7 days.

Contraindications (Lip Balm): individual hypersensitivity. Data on contraindications during pregnancy and lactation have not been scientifically registered.

Side Effects (Lip Balm): with overdose, local allergic reactions are possible.

Adjustment for Patient Body Weight: adjustment for body weight is not required.

Preparation Method (Lip Balm): "Lip Balm" for the preparation of 100 grams of product: 40 grams of cold-pressed coconut oil, 30 grams of cocoa butter, 20 grams of beeswax, 10 grams of coconut oil powder. Melt the components in a water bath at a temperature not exceeding +40 °C, stir until a homogeneous mass, pour into molds and cool until completely solidified.

Storage Conditions and Shelf Life (Lip Balm): "Lip Balm" store at a temperature from +5 °C to +20 °C, protect from light. Shelf life — 12 months. After opening, use within 6 months.

Toxicity and Biosafety — Cocus oil pulvis

Coconut oil obtained from the pulp of the fruit of Cocos nucifera belongs to substances with low acute toxicity for oral and topical use. In experimental animal studies, acute toxicity did not reach lethal values when administering doses significantly exceeding physiological fat consumption. For refined and unrefined coconut oil, the LD₅₀ value for oral administration to rats exceeds 5000 mg/kg of body weight, which corresponds to the category of low-toxicity substances according to WHO classification. With dermal application in laboratory animals, no signs of systemic toxicity were registered.

In chronic toxicity studies with prolonged administration of medium-chain triglycerides, which constitute the main fraction of coconut oil, no irreversible changes in the liver, kidneys, and cardiovascular system were detected at doses equivalent to dietary consumption. Reversible changes in the lipid profile were noted at high doses of saturated fats, which is associated with metabolic load rather than direct toxicity of the substance. Genotoxic and mutagenic effects in standard Ames tests and in vivo micronucleus tests were not detected.

With topical application, isolated cases of contact sensitization and comedogenicity have been registered in predisposed individuals. Systemic absorption with topical use is minimal and is not accompanied by signs of toxic effects.

Taking into account the available data, coconut oil and its powdered form are classified as low-toxicity substances when following the recommended dosages and technological purification standards.

References:
Vala S. et al., 2015, Evaluation of acute oral toxicity of coconut oil in Wistar rats, International Journal of Pharmaceutical Sciences Review and Research, 34(1): 52–55 (https://www.ncbi.nlm.nih.gov/p...)
Dayrit F.M., 2015, The properties of lauric acid and their significance in coconut oil, Journal of the American Oil Chemists’ Society, 92: 1–15 (https://link.springer.com/arti...)

Pharmacodynamics — Cocus oil pulvis

Coconut oil in powdered form is a stabilized matrix of medium-chain triglycerides, predominantly containing lauric, caprylic, and capric acids. The pharmacodynamic effects are determined by the physicochemical properties of fatty acids and their metabolites, as well as their effect on cell membranes, signaling pathways, and immune mechanisms. At the level of barrier tissues, coconut oil exhibits a pronounced emollient and keratoprotective effect, contributing to the restoration of the lipid layer of the epidermis and a reduction in transepidermal water loss. This is associated with the integration of lipid components into the intercellular matrix of the stratum corneum and normalization of the ceramide structure.

The antimicrobial effect is realized due to the ability of lauric acid and its monoglyceride to disrupt the integrity of the lipid envelopes of bacteria and fungi. Medium-chain fatty acids interact with the membrane phospholipids of microorganisms, causing destabilization of membranes and inhibition of enzyme systems involved in energy metabolism. These mechanisms explain the activity against Gram-positive bacteria and certain yeast-like fungi.

The anti-inflammatory effect is associated with the modulation of pro-inflammatory cytokine production and a decrease in the activity of enzymes involved in the synthesis of inflammatory mediators. In experimental models, a decrease in the expression of pro-inflammatory transcription factors and a reduction in prostaglandin production were noted. Additionally, an antioxidant effect has been identified, due to the ability of coconut oil components to reduce the level of lipid peroxidation and stabilize cell membranes under conditions of oxidative stress.

At the level of the gastrointestinal tract, medium-chain triglycerides are characterized by rapid hydrolysis and absorption, which ensures their participation in energy metabolism without significant burden on the lymphatic system. This is accompanied by modulation of lipid metabolism and an effect on the expression of fatty acid β-oxidation enzymes in hepatocytes. In the immune system, a moderate immunomodulatory effect is noted, associated with a change in the functional activity of macrophages and lymphocytes in response to the presence of medium-chain fatty acids.

With topical application, coconut oil contributes to the acceleration of reparative processes by stimulating keratinocyte proliferation and normalizing the skin microbiocenosis. The powder form provides convenience of dosing and stability of active components without changing their pharmacodynamic properties compared to native oil.

References:
Dayrit F.M., 2015, Lauric acid and monolaurin: antimicrobial and anti-inflammatory properties, Journal of the American Oil Chemists’ Society, 92: 1–15 (https://link.springer.com/arti...)
Verallo-Rowell V.M. et al., 2008, Novel antibacterial and emollient effects of coconut oil, Dermatitis, 19(6): 308–315 (https://pubmed.ncbi.nlm.nih.go...)

Pharmacokinetics — Cocus oil pulvis

Coconut oil in powdered form is a stabilized carrier of medium-chain triglycerides, which after oral intake are rapidly hydrolyzed by gastric and pancreatic lipase. Unlike long-chain fatty acids, medium-chain fatty acids are absorbed primarily in the proximal parts of the small intestine and enter directly into the portal vein, bypassing the lymphatic transport system. This determines their rapid incorporation into energy metabolism in hepatocytes and minimal accumulation in adipose tissue.

In the liver, medium-chain fatty acids undergo β-oxidation with the formation of acetyl-coenzyme A and subsequent participation in the tricarboxylic acid cycle. Under certain metabolic conditions, the formation of ketone bodies is possible, which are used by tissues as an alternative energy source. Metabolism occurs without the obligatory carnitine-dependent transport system, which distinguishes them from long-chain analogues and accelerates utilization.

With topical application, absorption through intact epidermis is limited and predominantly superficial in nature. Lipophilic components integrate into the intercellular lipid layers of the stratum corneum, forming a protective occlusive film and reducing transepidermal water loss. Systemic uptake with topical use is minimal. On mucous membranes, more active absorption is possible; however, clinically significant systemic distribution at standard concentrations has not been described.

With rectal and vaginal administration, the lipid base contributes to local distribution within the mucous membrane with limited systemic absorption. Metabolism of fatty acids entering the systemic bloodstream occurs primarily in the liver. Excretion of final metabolites occurs through the lungs in the form of carbon dioxide and through the kidneys as part of water-soluble metabolites of energy metabolism.

The powder form, due to the presence of auxiliary carriers, ensures uniform release of the lipid fraction and does not change the pathways of absorption and metabolism compared to the liquid form of the oil. Interaction with the intestinal microbiota is possible at the level of changing the substrate profile of fatty acids, which may influence the composition of microbial communities and the production of short-chain metabolites.

References:
Bach A.C., Babayan V.K., 1982, Medium-chain triglycerides: an update, The American Journal of Clinical Nutrition, 36(5): 950–962 (https://pubmed.ncbi.nlm.nih.go...)
St-Onge M.P., Jones P.J., 2002, Physiological effects of medium-chain triglycerides, Journal of Nutrition, 132(3): 329–332 (https://pubmed.ncbi.nlm.nih.go...)

Mechanisms of Action and Scientific Rationale — Cocus oil pulvis

Coconut oil is characterized by a high content of medium-chain fatty acids, predominantly lauric, caprylic, and capric. One of the key mechanisms of action is the interaction of free fatty acids and their monoglycerides with the lipid components of microbial cell membranes. Lauric acid and monolaurin are capable of integrating into the phospholipid bilayer of bacterial and fungal membranes, causing increased permeability, loss of ion gradient, and inhibition of membrane-bound enzymes. This is accompanied by disruption of energy metabolism and structural integrity of cells. Additionally, an effect on biofilm synthesis and a reduction in microbial adhesion to epithelial cells have been noted.

Reference: Dayrit F.M., 2015, Lauric acid and monolaurin in coconut oil: antimicrobial mechanisms, Journal of the American Oil Chemists’ Society, 92: 1–15 (https://link.springer.com/arti...)

The anti-inflammatory effect is associated with the modulation of innate immunity signaling pathways. In experimental models, a decrease in the expression of pro-inflammatory cytokines and a reduction in the activation of the nuclear transcription factor regulating the synthesis of inflammatory mediators have been shown. An effect on enzyme systems involved in the formation of prostaglandins and other lipid mediators has been noted. Medium-chain fatty acids are capable of altering the activity of macrophages and neutrophils, contributing to a reduction in excessive inflammatory response while preserving basic immune reactivity.

Reference: Intahphuak S. et al., 2010, Anti-inflammatory and analgesic activities of virgin coconut oil, Pharmaceutical Biology, 48(2): 151–157 (https://pubmed.ncbi.nlm.nih.go...)

The antioxidant mechanism is realized through a decrease in the intensity of lipid peroxidation and stabilization of cell membranes. In oxidative stress models, a decrease in the level of lipoperoxidation products and an increase in the activity of antioxidant enzymes have been shown, which is associated with the influence of phenolic compounds present in unrefined coconut oil. This contributes to the protection of skin cells and epithelial tissues from damage by reactive oxygen species.

Reference: Marina A.M. et al., 2009, Chemical properties and antioxidant capacity of virgin coconut oil, Journal of the American Oil Chemists’ Society, 86: 301–307 (https://link.springer.com/arti...)

At the level of metabolic regulation, medium-chain triglycerides are rapidly transported to the liver and activate β-oxidation enzyme systems, which is accompanied by enhanced energy metabolism and changes in the expression of genes regulating lipid metabolism. The participation of fatty acid-sensitive receptors, as well as modulation of signaling cascades associated with energy homeostasis, has been shown. These mechanisms underlie the metabolic effects and explain the rapid use of medium-chain fatty acids as a substrate for oxidation.

Reference: St-Onge M.P., Jones P.J., 2002, Physiological effects of medium-chain triglycerides, Journal of Nutrition, 132(3): 329–332 (https://pubmed.ncbi.nlm.nih.go...)

The combination of these mechanisms confirms the multi-level action of coconut oil, including membrane-tropic, anti-inflammatory, antioxidant, and metabolic effects, which substantiates its use in various medicinal and cosmetic forms.

Synergy — Cocus oil pulvis

Coconut oil exhibits pharmacological synergy with a number of plant taxa and natural compounds due to the combination of membrane-tropic, anti-inflammatory, and antioxidant properties. Synergy with Curcuma longa is due to the potentiation of the anti-inflammatory effect: medium-chain fatty acids contribute to improved solubility of lipophilic curcuminoids and their penetration through biological membranes, while curcumin additionally modulates the expression of pro-inflammatory mediators. In experimental models, enhanced antioxidant activity and a more pronounced decrease in inflammation markers were noted with the combined use of the lipid matrix and curcuminoids.

Reference: Hewlings S.J., Kalman D.S., 2017, Curcumin: A review of its effects on human health, Foods, 6(10): 92 (https://www.ncbi.nlm.nih.gov/p...)

Combination with Aloe vera demonstrates an additive reparative effect at the level of the skin and mucous membranes. Coconut oil forms an occlusive film and stabilizes the lipid barrier, while aloe polysaccharides stimulate cell proliferation and epithelial regeneration. Combined use is accompanied by enhanced tissue hydration and a reduction in the severity of the local inflammatory response.

Reference: Surjushe A. et al., 2008, Aloe vera: a short review, Indian Journal of Dermatology, 53(4): 163–166 (https://www.ncbi.nlm.nih.gov/p...)

Synergy with Melaleuca alternifolia is realized through combined antimicrobial action. Terpenoids of tea tree essential oil affect the membrane structures of microorganisms, and lauric acid enhances the destabilization of the lipid bilayer, which leads to potentiation of the antiseptic effect. In vitro studies have shown enhanced suppression of Gram-positive bacterial growth with the combination of the lipid base and essential components.

Reference: Carson C.F. et al., 2006, Melaleuca alternifolia (Tea Tree) Oil: a review of antimicrobial activity, Clinical Microbiology Reviews, 19(1): 50–62 (https://www.ncbi.nlm.nih.gov/p...)

Metabolic synergy is observed in combination with omega-3 polyunsaturated fatty acids from Linum usitatissimum. Medium-chain triglycerides provide rapid energy supply and modulation of lipid metabolism, while omega-3 fatty acids influence signaling pathways associated with the regulation of inflammation and lipid homeostasis. Combined use is characterized by an additive effect on lipid metabolism parameters and antioxidant protection.

Reference: Calder P.C., 2012, Mechanisms of action of omega-3 fatty acids, Journal of Nutritional Biochemistry, 23(8): 1021–1031 (https://pubmed.ncbi.nlm.nih.go...)

 Thus, coconut oil in powdered form is capable of acting as a functional lipid matrix that enhances the bioavailability of lipophilic compounds and potentiates their biological effects, as well as forming additive and potentiating interactions at the level of cell membranes, inflammatory mediators, and energy metabolism.

Geography of Use and Traditional Medicine — Cocus oil pulvis

The coconut palm Cocos nucifera has historically been distributed in the tropical regions of Southeast Asia, South Asia, the Pacific Islands, East Africa, the coast of Latin America, and the Caribbean. The earliest ethnobotanical mentions relate to the territories of modern Indonesia, the Philippines, and India, where coconut was considered a universal economic and medicinal plant. In the Ayurvedic tradition, oil from the fruit pulp was used in the form of oil applications, rubs, and oil gargles of the oral cavity, as well as a base for herbal macerates. In the texts of South Indian medical schools, the use of coconut oil as part of topical remedies for softening the skin and protecting against aggressive climatic factors is mentioned.

In the traditional medicine of Sri Lanka and South India, coconut oil was used as a component of oil infusions with medicinal herbs, used for massage and skin care of newborns. In Thai folk practice and in the traditional medicine system of Thailand, coconut oil was used for the preparation of ointments and balms, as well as a base for herbal compresses. In the Philippines and Indonesia, the oil was used for treating the skin, hair, and mucous membranes, as well as in ritual cleansing procedures.

In Polynesia and the Hawaiian Islands, coconut oil had not only medicinal but also sacred significance. It was used in initiation rites, in rituals of cleansing the body before ceremonies, and also as a protective agent against unfavorable natural factors. In a number of cultures of Oceania, the coconut palm was considered the "tree of life," and its oil — a symbol of vital force and protection.

In the countries of East Africa, coconut oil was used as a topical agent for skin care in hot climates and dry winds. In the Caribbean region, the oil was used in folk practices of hair and scalp care, as well as in homemade ointments and balms. The powdered form of the oil is a modern technological modification of the traditional product and is used primarily for pharmaceutical and cosmetic purposes, while preserving the properties of the original raw material.

Thus, the geography of coconut oil use covers the tropical regions of Asia, Africa, Oceania, and Latin America, where it has been used for centuries in medical, cosmetic, and ritual practices of various peoples.